Xilio Therapeutics (XLO) Operating Income Growth (3y) (2023 - 2026)
Xilio Therapeutics (XLO) Operating Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 38.78% |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | 13.47% |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | -12.10% |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | 89.72% |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | 55.96% |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | - |
| 10 | Xilio Therapeutics | 149.09 Mn | -1.21 Mn | - | 15.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.66% |
| Dec 31, 2025 | 20.06% |
| Sep 30, 2025 | 54.30% |
| Jun 30, 2025 | 16.36% |
| Mar 31, 2025 | 13.26% |
| Dec 31, 2024 | 11.34% |
| Sep 30, 2024 | 2.57% |
| Jun 30, 2024 | 13.86% |
| Mar 31, 2024 | -1.91% |
| Dec 31, 2023 | 4.16% |
| Sep 30, 2023 | -5.89% |